Please do not adjust margins
Catalysis Science & Technology
Page 4 of 5
DOI: 10.1039/C7CY00882A
COMMUNICATION
Journal Name
possessing 5 permanent bound molecules are currently conducting.
Vietnam National University-Ho Chi Minh City (VNU-HCM) is
acknowledged for financial support via grant No. B2015-20-04.
Notes and references
[1] (a) C. Bouteiller, J. B.-Ortega, P. Marchand, O. Nicole, L. Barre, A.
Buisson, and C. Perrio, Org. Biomol. Chem. 2010, 8, 1111–1120. (b) F. D.
Klingler, Acc. Chem. Res. 2007, 40, 1367–1376. (c) F. J. Sardina, and H.
Rapoport, Chem. Rev. 1996, 96, 1825–1872.
Scheme 2. Tentative reaction mechanism
Subsequently, the reaction mechanism was proposed (Scheme 2).
α-Bromination of carbonyl compounds under copper catalysis to
generate α-bromo carbonyls followed by nucleophilic substitution
by N-H amines. In fact, the synthesized α-bromo ethylphenylketone
facilely reacted with morpholine to afford desired product in
excellent yield (see Supporting Information).
[2] N. B. Mehta, J. Clin. Psychiat. 1983, 45, 56.
[3] (a) D. Sandoval, C. P. Frazier, A. Bugarin, and J. R. deAlaniz, J. Am. Chem.
Soc. 2012, 134, 18948–18951. (b) P. Selig, Angew. Chem., Int. Ed. 2013,
52, 7080–7082.
[4] (a) J. M. Janey, Angew. Chem., Int. Ed. 2005, 44, 4292–4300. (b) T.
Vilaivan, and W. Bhanthumnavin, Molecules, 2010, 15, 917–958.
[5] R. W. Evans, J. R. Zbieg, S. Zhu, W. Li, and D. W. C. MacMillan, J. Am.
Chem. Soc. 2013, 135, 16074–16077.
To highlight the generality of VNU-18 within oxidative amination,
the synthesis of high-profile relevant medicinal agents were carried
out utilizing the optimized conditions. The use of heterogeneous
catalyst in pharmaceutical industry is highly
[6] C. E. Garrett, and K. Prasad, Adv. Synth. Catal. 2004, 346, 889–900.
[7] J. G. Vries, S. D. Jackson, Catal. Sci. Technol., 2012, 2, 2009–2009.
[8] (a) W. Lu, Z. Wei, Z.-Y. Gu, T.-F. Liu, J. Park, J. Park, J. Tian, M. Zhang, Q.
Zhang, T. Gentle III, M. Boscha, and H.-C. Zhou, Chem. Soc. Rev. 2014,
43, 5561–5593. (b) O. M. Yaghi, M. O'Keeffe, N. W. Ockwig, H. K. Chae,
M. Eddaoudi, and J. Kim, Nature, 2013, 423, 705–714.
[9] (a) A. Corma, H. García, and F. X. Llabrés i Xamena, Chem. Rev., 2010,
110, 4606–4655. (b) J. Liu, L. Chen, H. Cui, J. Zhang, L. Zhang, and C.-Y.
Su, Chem. Soc. Rev., 2014, 43, 6011–6061.
[10](a) I. Luz, F. X. Llabrés i Xamena, and A. Corma, J. Catal. 2012, 285, 285–
291. (b) I. Luz, F. X. Llabrés i Xamena, and A. Corma, J. Catal. 2010, 276,
134–140.
[11]D. J. Tranchemontagne, J. L. Mendoza-Cortes, M. O'Keeffe, and O. M.
Yaghi, Chem. Soc. Rev. 2009, 38, 1257–1283.
Scheme 3. Synthetic scheme of medical agents conducted by the optimized
[12](a) K. Sumida, D. L. Rogow, J. A. Mason, T. M. McDonald, E. D. Bloch, Z.
R. Herm, T. H. Bae, and J. R. Long, Chem. Rev. 2012, 112, 724–781. (b)
M. P. Suh, H. J. Park, T. K. Prasad, and D. W. Lim, Chem. Rev. 2012, 112,
782–835. (c) K. Tan, N. Nijem, P. Canepa, Q. Gong, J. Li, T. Thonhauser,
and Y. J Chaba, Chem. Mater. 2012, 24, 3153–3167. (d) M. Bosch, M.
Zhang, and H.-C. Zhou Adv. Chem. 2014, Article ID 182327.
[13](a) H. T. N. Le, T. V. Tran, N. T. S. Phan, and T. Truong, Catal. Sci. Technol.
2015, 5, 851–859. (b) G. H. Dang, T. T. Dang, D. T. Le, T. Truong, and N.
T. S. Phan, J. Catal. 2014, 319, 258–264.
conditions under VNU-18 catalyst.
preferred due to the avoid of removal of toxic contaminated metals
in final products and cost reduction.19 Particularly, racemic of
Clopidogrel (Plavix), an agent to prevent blood clot, Amfepramone,
an appetite suppressant, and α-pyrrolidinovalerophenone (α-PVP),
an dopamine transporters (DAT), were achieved in reasonale yields
in one-step manner under VNU-18 catalysis protocol from
commercially available starting materials (eq. 1-3, Scheme 3). The
utility of air atmosphere instead of oxygen, ligand-free, ambient
temperature, and heterogeneous catalyst makes the method more
operational.
[14]W. Y. Gao, R. Cai, T. Pham, K. A. Forrest, A. Hogan, P. Nugent, K.
Williams, L. Wojtas, R. Luebke, L. J. Weseliński, M. J. Zaworotko, B.
Space, Y. S. Chen, M. Eddaoudi, X. Shi, and S. Ma, Chem. Mater. 2015,
27, 2144–2151.
In summary, we have presented the synthesis of copper-based
metal-organic framework, VNU-18, with copper cluster possesses
three kinds of geometrical cluster units, which is unprecedentedly
reported in MOFs chemistry based Cu-oxo cluster. Full
characterization for VNU-18 including the single crystal and powder
X-ray diffraction analysis, thermogravimetrical analysis, and N2
adsorption measurement at low pressure and 77 K were also
disclosed. Furthermore, this material was demonstrated as active
catalyst for direct coupling of wide range of carbonyls and N-H
amines. Leaching test and recycling studies indicated the
heterogeneity of VNU-18 while other reported Cu-MOFs or
common heterogeneous materials were inefficient. Gratifyingly, the
synthesis of prominent pharmaceutical agents was also performed
using optimized conditions. More research to support the chemical
resistance and excellent activity of this copper-oxo cluster
[15] (a) E.-C. Yang, Y-L. Yang, Z.-Y. Liu, K-S. Liu, X.-Y. Wu and X.-J. Zhao,
CrystEngComm, 2011, 7, 2667–2673. (b) X.-L. Wang, B. Mu, H.-Y. Lin, S.
Yang, G.-C. Liu, J. Mol. Struct. 2013, 1036, 380–385. (c) C. Chen, P. Shen,
M. Wan, N. Ding, X. Shi, X. Wang, N. Zhang, Micropor. Mesopor. Mat.
2016, 232, 167–173.
[16](a) M. Zhang, L. Zhang, Z. Xiao, Q. Zhang, R. Wang, F. Dai, and D. Sun, Sci.
Rep. 2016, 6, 20672. (b) X. Meng, S-Y. Song, X.-Z. Song, M. Zhu, S-N.
Zhao, L.-L. Wu, and H.-J. Zhan, Chem. Commun. 2015, 51, 8150–8152.
[17]A. L. J. Spek, J. Appl. Crystallogr. 2003, 36, 7–13.
[18]V. A. Blatov, A. P. Shevchenko, and D. M. Proserpio, Cryst. Growth Des.
2014, 14, 3576–3586.
[19]C. J. Welch, J. Albaneze-Walker, W. R. Leonard, M. Biba, J. DaSilva, D.
Henderson, B. Laing, D. J. Mathre, S. Spencer, X. Bu, and T. Wang, Org.
Process Res. Dev. 2005, 9, 198–205.
4 | J. Name., 2012, 00, 1-3
This journal is © The Royal Society of Chemistry 20xx
Please do not adjust margins